Last reviewed · How we verify
Methylprednisolone and azathioprine
Methylprednisolone and azathioprine is a Small molecule drug developed by Xiaoli Fan. It is currently FDA-approved.
Methylprednisolone and azathioprine, marketed by Xiaoli Fan, is a combination therapy currently available in the market. The key composition patent is set to expire in 2028, providing a period of exclusivity that supports current market positioning. The primary risk is the potential increase in competition following the patent expiry in 2028.
At a glance
| Generic name | Methylprednisolone and azathioprine |
|---|---|
| Sponsor | Xiaoli Fan |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease (PHASE4)
- Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR (PHASE4)
- Micophenolate Mofetil Versus Azathioprine in Myocarditis (PHASE3)
- Protein A immuNoaDsorption for the Treatment of Acute Episodes of Neuromyelitis Optica Spectrum Disorder (NA)
- Immunosuppressive Therapy Alone Versus Plus Oral Anticoagulation in the Treatment of VT Associated With Behcet's Disease (PHASE3)
- Immediate Versus Delayed Treatment With Azathioprine or Rituximab in Anti-MOG Antibodies Associated Acute Demyelinating Syndromes in Children: a Randomized Controlled Clinical Trial (PHASE3)
- A Study to Evaluate the Safety and Efficacy of Satralizumab in Participants With Neuromyelitis Optica Spectrum Disorder (NMOSD) (PHASE3)
- The Effect of Mycophenolate Mofetil and Cyclophosphamide on the Lymphocyte Subsets in Patients With Proliferative Lupus Nephritis (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Methylprednisolone and azathioprine CI brief — competitive landscape report
- Methylprednisolone and azathioprine updates RSS · CI watch RSS
- Xiaoli Fan portfolio CI